Ethnobotany and the role of plant natural products in antibiotic drug discovery

G Porras, F Chassagne, JT Lyles, L Marquez… - Chemical …, 2020 - ACS Publications
The crisis of antibiotic resistance necessitates creative and innovative approaches, from
chemical identification and analysis to the assessment of bioactivity. Plant natural products …

[HTML][HTML] New tuberculosis drug targets, their inhibitors, and potential therapeutic impact

GS Shetye, SG Franzblau, S Cho - Translational Research, 2020 - Elsevier
The current tuberculosis (TB) predicament poses numerous challenges and therefore every
incremental scientific work and all positive socio-political engagements, are steps taken in …

Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H) …

X Li, V Hernandez, FL Rock, W Choi… - Journal of medicinal …, 2017 - ACS Publications
There is an urgent need to develop new and safer antitubercular agents that possess a
novel mode of action. We synthesized and evaluated a novel series of 3-aminomethyl 4 …

The struggle to end a millennia-long pandemic: novel candidate and repurposed drugs for the treatment of tuberculosis

BD Edwards, SK Field - Drugs, 2022 - Springer
This article provides an encompassing review of the current pipeline of putative and
developed treatments for tuberculosis, including multidrug-resistant strains. The review has …

Challenging the drug-likeness dogma for new drug discovery in tuberculosis

D Machado, M Girardini, M Viveiros… - Frontiers in …, 2018 - frontiersin.org
The emergence of multi-and extensively drug resistant tuberculosis worldwide poses a great
threat to human health and highlight the need to discover and develop new, effective and …

Optimizing cardio, hepato and phospholipidosis toxicity of the Bedaquiline by chemoinformatics and molecular modelling approach

R Girase, I Ahmad, R Pawara… - SAR and QSAR in …, 2022 - Taylor & Francis
The FDA granted expedited approval for Johnson and Johnson's Bedaquiline to treat
pulmonary multidrug resistant tuberculosis on 28 December 2012 which is more common in …

S2k-Leitlinie: Tuberkulose im Erwachsenenalter

T Schaberg, T Bauer, F Brinkmann, R Diel… - …, 2017 - thieme-connect.com
In Deutschland ist seit 2015 ein deutlicher Anstieg der gemeldeten Tuberkulosefälle zu
verzeichnen. Zurückzuführen ist dieser vor allem auf die aktuell vermehrte Migration. Durch …

Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug-resistant tuberculosis: a retrospective cohort study

Y Zhao, T Fox, K Manning, A Stewart… - Clinical Infectious …, 2019 - academic.oup.com
Background Bedaquiline is used as a substitute for second-line injectable (SLI) intolerance
in the treatment of multidrug-resistant (MDR) tuberculosis, but the efficacy and safety of this …

Targeting bacterial energetics to produce new antimicrobials

K Hards, GM Cook - Drug Resistance Updates, 2018 - Elsevier
From the war on drug resistance, through cancer biology, even to agricultural and
environmental protection: there is a huge demand for rapid and effective solutions to control …

Chemical classes presenting novel antituberculosis agents currently in different phases of drug development: A 2010–2020 review

KT Angula, LJ Legoabe, RM Beteck - Pharmaceuticals, 2021 - mdpi.com
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a curable airborne
disease currently treated using a drug regimen consisting of four drugs. Global TB control …